Strain engineering for improved expression of recombinant proteins in bacteria

Microbial Cell Factories

Volumn 10, Issue , 2011, Pages

  Makino, Tomohiro ^a,b,d   Skretas, Georgios ^c   Georgiou, George ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c INSTITUTE OF BIOLOGY   (Greece)

^d DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; RECOMBINANT PROTEIN;

BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; DISULFIDE BOND; ESCHERICHIA COLI; GENETIC ENGINEERING; GENETIC SELECTION; HIGH THROUGHPUT SCREENING; LACTOBACILLUS PLANTARUM; MUTAGENESIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW; RNA STABILITY; SACCHAROMYCES CEREVISIAE; STREPTOMYCES FRADIAE; TRANSLATION REGULATION; BIOSYNTHESIS; CYTOPLASM; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ESCHERICHIA COLI;

ESCHERICHIA COLI; GENETIC ENGINEERING; HIGH-THROUGHPUT SCREENING ASSAYS; PERIPLASM; RECOMBINANT PROTEINS;

EID: 79955813920     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-10-32     Document Type: Review

References (95)

1. Burgess-Brown NA, Sharma S, Sobott F, Loenarz C, Oppermann U, Gileadi O. Codon optimization can improve expression of human genes in Escherichia coli: A multi-gene study. Protein Expr Purif 2008, 59(1):94-102. 10.1016/j.pep.2008.01.008, 18289875.
2. Jung ST, Kang TH, Georgiou G. Efficient expression and purification of human aglycosylated Fcgamma receptors in Escherichia coli. Biotechnol Bioeng 2010, 107(1):21-30. 10.1002/bit.22785, 20506277.
3. Simmons LC, Yansura DG. Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli. Nat Biotechnol 1996, 14(5):629-634. 10.1038/nbt0596-629, 9630956.
4. Wu X, Jornvall H, Berndt KD, Oppermann U. Codon optimization reveals critical factors for high level expression of two rare codon genes in Escherichia coli: RNA stability and secondary structure but not tRNA abundance. Biochem Biophys Res Commun 2004, 313(1):89-96. 10.1016/j.bbrc.2003.11.091, 14672702.
5. Pfleger BF, Pitera DJ, Smolke CD, Keasling JD. Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nat Biotechnol 2006, 24(8):1027-1032. 10.1038/nbt1226, 16845378.
6. Hatfield GW, Roth DA. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering. Biotechnol Annu Rev 2007, 13:27-42.
7. Kudla G, Murray AW, Tollervey D, Plotkin JB. Coding-sequence determinants of gene expression in Escherichia coli. Science 2009, 324(5924):255-258. 10.1126/science.1170160, 19359587.
8. Cho HJ, Lee Y, Chang RS, Hahm MS, Kim MK, Kim YB, Oh YK. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli. Protein Expr Purif 2008, 60(1):37-45. 10.1016/j.pep.2008.03.018, 18455434.
9. Kapust RB, Waugh DS. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 1999, 8(8):1668-1674. 10.1110/ps.8.8.1668, 2144417, 10452611.
10. Rabhi-Essafi I, Sadok A, Khalaf N, Fathallah DM. A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli. Protein Eng Des Sel 2007, 20(5):201-209. 10.1093/protein/gzm012, 17430974.
11. de Marco A. Protocol for preparing proteins with improved solubility by co-expressing with molecular chaperones in Escherichia coli. Nat Protoc 2007, 2(10):2632-2639. 10.1038/nprot.2007.400, 17948006.
12. Graves PE, Henderson DP, Horstman MJ, Solomon BJ, Olson JS. Enhancing stability and expression of recombinant human hemoglobin in E. coli: Progress in the development of a recombinant HBOC source. Biochim Biophys Acta 2008, 1784(10):1471-1479.
13. Sarkar CA, Dodevski I, Kenig M, Dudli S, Mohr A, Hermans E, Pluckthun A. Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity. Proc Natl Acad Sci USA 2008, 105(39):14808-14813. 10.1073/pnas.0803103105, 2567449, 18812512.
14. Fisher AC, DeLisa MP. Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery. J Mol Biol 2009, 385(1):299-311. 10.1016/j.jmb.2008.10.051, 2612092, 18992254.
15. Seo MJ, Jeong KJ, Leysath CE, Ellington AD, Iverson BL, Georgiou G. Engineering antibody fragments to fold in the absence of disulfide bonds. Protein Sci 2009, 18(2):259-267. 10.1002/pro.31, 2708069, 19177559.
16. Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 2004, 22(11):1399-1408. 10.1038/nbt1029, 15529165.
17. Choi JH, Lee SY. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 2004, 64(5):625-635. 10.1007/s00253-004-1559-9, 14966662.
18. Georgiou G, Segatori L. Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr Opin Biotechnol 2005, 16(5):538-545. 10.1016/j.copbio.2005.07.008, 16095898.
19. Gottesman S. Proteases and their targets in Escherichia coli. Annu Rev Genet 1996, 30:465-506. 10.1146/annurev.genet.30.1.465, 8982462.
20. Lopez PJ, Marchand I, Joyce SA, Dreyfus M. The C-terminal half of RNase E, which organizes the Escherichia coli degradosome, participates in mRNA degradation but not rRNA processing in vivo. Mol Microbiol 1999, 33(1):188-199. 10.1046/j.1365-2958.1999.01465.x, 10411735.
21. Baca AM, Hol WG. Overcoming codon bias: a method for high-level overexpression of Plasmodium and other AT-rich parasite genes in Escherichia coli. Int J Parasitol 2000, 30(2):113-118. 10.1016/S0020-7519(00)00019-9, 10704592.
22. Sorensen HP, Sperling-Petersen HU, Mortensen KK. Production of recombinant thermostable proteins expressed in Escherichia coli: completion of protein synthesis is the bottleneck. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 786(1-2):207-214. 10.1016/S1570-0232(02)00689-X, 12651016.
23. Houry WA. Chaperone-assisted protein folding in the cell cytoplasm. Curr Protein Pept Sci 2001, 2(3):227-244. 10.2174/1389203013381134, 12369934.
24. Bothmann H, Pluckthun A. The periplasmic Escherichia coli peptidylprolyl cis, trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines. J Biol Chem 2000, 275(22):17100-17105. 10.1074/jbc.M910233199, 10748200.
25. Hu X, O'Hara L, White S, Magner E, Kane M, Wall JG. Optimisation of production of a domoic acid-binding scFv antibody fragment in Escherichia coli using molecular chaperones and functional immobilisation on a mesoporous silicate support. Protein Expr Purif 2007, 52(1):194-201. 10.1016/j.pep.2006.08.009, 17005419.
26. Link AJ, Skretas G, Strauch EM, Chari NS, Georgiou G. Efficient production of membrane-integrated and detergent-soluble G protein-coupled receptors in Escherichia coli. Protein Sci 2008, 17(10):1857-1863. 10.1110/ps.035980.108, 2548370, 18593817.
27. Nishihara K, Kanemori M, Yanagi H, Yura T. Overexpression of trigger factor prevents aggregation of recombinant proteins in Escherichia coli. Appl Environ Microbiol 2000, 66(3):884-889. 10.1128/AEM.66.3.884-889.2000, 91917, 10698746.
28. Skretas G, Carroll S, DeFrees S, Schwartz MF, Johnson KF, Georgiou G. Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli. Microb Cell Fact 2009, 8:50. 10.1186/1475-2859-8-50, 2762462, 19788761.
29. Genevaux P, Keppel F, Schwager F, Langendijk-Genevaux PS, Hartl FU, Georgopoulos C. In vivo analysis of the overlapping functions of DnaK and trigger factor. EMBO Rep 2004, 5(2):195-200. 10.1038/sj.embor.7400067, 1298978, 14726952.
30. Saul FA, Arie JP, Vulliez-le Normand B, Kahn R, Betton JM, Bentley GA. Structural and functional studies of FkpA from Escherichia coli, a cis/trans peptidyl-prolyl isomerase with chaperone activity. J Mol Biol 2004, 335(2):595-608. 10.1016/j.jmb.2003.10.056, 14672666.
31. de Marco A, Deuerling E, Mogk A, Tomoyasu T, Bukau B. Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol 2007, 7:32. 10.1186/1472-6750-7-32, 1904446, 17565681.
32. Kadokura H, Katzen F, Beckwith J. Protein disulfide bond formation in prokaryotes. Annu Rev Biochem 2003, 72:111-135. 10.1146/annurev.biochem.72.121801.161459, 12524212.
33. de Marco A. Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli. Microb Cell Fact 2009, 8:26. 10.1186/1475-2859-8-26, 2689190, 19442264.
34. Kurokawa Y, Yanagi H, Yura T. Overproduction of bacterial protein disulfide isomerase (DsbC) and its modulator (DsbD) markedly enhances periplasmic production of human nerve growth factor in Escherichia coli. J Biol Chem 2001, 276(17):14393-14399.
35. Qiu J, Swartz JR, Georgiou G. Expression of active human tissue-type plasminogen activator in Escherichia coli. Appl Environ Microbiol 1998, 64(12):4891-4896. 90939, 9835579.
36. Bessette PH, Aslund F, Beckwith J, Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci USA 1999, 96(24):13703-13708. 10.1073/pnas.96.24.13703, 24128, 10570136.
37. Faulkner MJ, Veeravalli K, Gon S, Georgiou G, Beckwith J. Functional plasticity of a peroxidase allows evolution of diverse disulfide-reducing pathways. Proc Natl Acad Sci USA 2008, 105(18):6735-6740. 10.1073/pnas.0801986105, 2373332, 18456836.
38. Nguyen VDHF, Salo KE, Enlund E, Zhang C, Ruddock LW. Pre-expression of a sulfhydryl oxidase significantly increases the yields of eukaryotic disulfide bond containing proteins expressed in the cytoplasm of E.coli. Microb Cell Fact 2011, 10(1):1. 10.1186/1475-2859-10-1, 3022669, 21211066.
39. Hatahet FNV, Salo KE, Ruddock LW. Disruption of reducing pathways is not essential for efficient disulfide bond formation in the cytoplasm of E. coli. Microb Cell Fact 2010, 13(9):67.
40. Wacker M, Linton D, Hitchen PG, Nita-Lazar M, Haslam SM, North SJ, Panico M, Morris HR, Dell A, Wren BW, et al. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 2002, 298(5599):1790-1793. 10.1126/science.298.5599.1790, 12459590.
41. Linton D, Dorrell N, Hitchen PG, Amber S, Karlyshev AV, Morris HR, Dell A, Valvano MA, Aebi M, Wren BW. Functional analysis of the Campylobacter jejuni N-linked protein glycosylation pathway. Mol Microbiol 2005, 55(6):1695-1703. 10.1111/j.1365-2958.2005.04519.x, 15752194.
42. Pandhal J, Wright PC. N-Linked glycoengineering for human therapeutic proteins in bacteria. Biotechnol Lett 2010, 32(9):1189-1198. 10.1007/s10529-010-0289-6, 20449632.
43. Pandhal JOS, Noirel J, Wright PC. Improving N-glycosylation efficiency in Escherichia coli using shotgun proteomics, metabolic network analysis, and selective reaction monitoring. Biotechnol Bioeng 2010,
44. Feldman MF, Wacker M, Hernandez M, Hitchen PG, Marolda CL, Kowarik M, Morris HR, Dell A, Valvano MA, Aebi M. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci USA 2005, 102(8):3016-3021. 10.1073/pnas.0500044102, 549450, 15703289.
45. Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Thony-Meyer L. Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact 2010, 9:61. 10.1186/1475-2859-9-61, 2927510, 20701771.
46. Celik E, Fisher AC, Guarino C, Mansell TJ, Delisa MP. A filamentous phage display system for N-linked glycoproteins. Protein Sci 2010,
47. Durr C, Nothaft H, Lizak C, Glockshuber R, Aebi M. The Escherichia coli glycophage display system. Glycobiology 2010, 20(11):1366-1372. 10.1093/glycob/cwq102, 20581006.
48. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation?. EMBO J 2000, 19(6):1176-1179. 10.1093/emboj/19.6.1176, 305658, 10716917.
49. Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, Varhaug JE, Vandekerckhove J, Lillehaug JR, Sherman F, et al. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(20):8157-8162. 10.1073/pnas.0901931106, 2688859, 19420222.
50. Gautschi M, Just S, Mun A, Ross S, Rucknagel P, Dubaquie Y, Ehrenhofer-Murray A, Rospert S. The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides. Mol Cell Biol 2003, 23(20):7403-7414. 10.1128/MCB.23.20.7403-7414.2003, 230319, 14517307.
51. Soppa J. Protein acetylation in archaea, bacteria, and eukaryotes. Archaea 2010, 2010.
52. Fang H, Zhang X, Shen L, Si X, Ren Y, Dai H, Li S, Zhou C, Chen H. RimJ is responsible for N(alpha)-acetylation of thymosin alpha1 in Escherichia coli. Appl Microbiol Biotechnol 2009, 84(1):99-104. 10.1007/s00253-009-1994-8, 19352641.
53. Johnson M, Coulton AT, Geeves MA, Mulvihill DP. Targeted amino-terminal acetylation of recombinant proteins in E. coli. PLoS One 2010, 5(12):e15801. 10.1371/journal.pone.0015801, 3009751, 21203426.
54. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006, 2. 2006 0008.
55. Alper H, Stephanopoulos G. Global transcription machinery engineering: a new approach for improving cellular phenotype. Metab Eng 2007, 9(3):258-267. 10.1016/j.ymben.2006.12.002, 17292651.
56. Warner JR, Reeder PJ, Karimpour-Fard A, Woodruff LB, Gill RT. Rapid profiling of a microbial genome using mixtures of barcoded oligonucleotides. Nat Biotechnol 2010,
57. Carr PA, Church GM. Genome engineering. Nat Biotechnol 2009, 27(12):1151-1162. 10.1038/nbt.1590, 20010598.
58. Miroux B, Walker JE. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol 1996, 260(3):289-298. 10.1006/jmbi.1996.0399, 8757792.
59. Wagner S, Klepsch MM, Schlegel S, Appel A, Draheim R, Tarry M, Hogbom M, van Wijk KJ, Slotboom DJ, Persson JO, et al. Tuning Escherichia coli for membrane protein overexpression. Proc Natl Acad Sci USA 2008, 105(38):14371-14376. 10.1073/pnas.0804090105, 2567230, 18796603.
60. Massey-Gendel E, Zhao A, Boulting G, Kim HY, Balamotis MA, Seligman LM, Nakamoto RK, Bowie JU. Genetic selection system for improving recombinant membrane protein expression in E. coli. Protein Sci 2009, 18(2):372-383. 10.1002/pro.39, 2708063, 19165721.
61. Makino T, Skretas G, Kang TH, Georgiou G. Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies. Metab Eng 2011, 13(2):241-251. 10.1016/j.ymben.2010.11.002, 21130896.
62. Skretas G, Georgiou G. Genetic analysis of G protein-coupled receptor expression in Escherichia coli: inhibitory role of DnaJ on the membrane integration of the human central cannabinoid receptor. Biotechnol Bioeng 2009, 102(2):357-367. 10.1002/bit.22097, 2666920, 18828176.
63. Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E, Toyonaga H, Mori H. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res 2005, 12(5):291-299.
64. Skretas G, Georgiou G. Simple genetic selection protocol for isolation of overexpressed genes that enhance accumulation of membrane-integrated human G protein-coupled receptors in Escherichia coli. Appl Environ Microbiol 2010, 76(17):5852-5859. 10.1128/AEM.00963-10, 2935035, 20639362.
65. Santos CN, Stephanopoulos G. Combinatorial engineering of microbes for optimizing cellular phenotype. Curr Opin Chem Biol 2008, 12(2):168-176. 10.1016/j.cbpa.2008.01.017, 18275860.
66. Klein-Marcuschamer D, Santos CN, Yu H, Stephanopoulos G. Mutagenesis of the bacterial RNA polymerase alpha subunit for improvement of complex phenotypes. Appl Environ Microbiol 2009, 75(9):2705-2711. 10.1128/AEM.01888-08, 2681691, 19251886.
67. Alper H, Moxley J, Nevoigt E, Fink GR, Stephanopoulos G. Engineering yeast transcription machinery for improved ethanol tolerance and production. Science 2006, 314(5805):1565-1568. 10.1126/science.1131969, 17158319.
68. Yu H, Tyo K, Alper H, Klein-Marcuschamer D, Stephanopoulos G. A high-throughput screen for hyaluronic acid accumulation in recombinant Escherichia coli transformed by libraries of engineered sigma factors. Biotechnol Bioeng 2008, 101(4):788-796. 10.1002/bit.21947, 18500764.
69. Park KS, Lee DK, Lee H, Lee Y, Jang YS, Kim YH, Yang HY, Lee SI, Seol W, Kim JS. Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors. Nat Biotechnol 2003, 21(10):1208-1214. 10.1038/nbt868, 12960965.
70. Lee JY, Sung BH, Yu BJ, Lee JH, Lee SH, Kim MS, Koob MD, Kim SC. Phenotypic engineering by reprogramming gene transcription using novel artificial transcription factors in Escherichia coli. Nucleic Acids Res 2008, 36(16):e102. 10.1093/nar/gkn449, 2532725, 18641039.
71. Park KS, Jang YS, Lee H, Kim JS. Phenotypic alteration and target gene identification using combinatorial libraries of zinc finger proteins in prokaryotic cells. J Bacteriol 2005, 187(15):5496-5499. 10.1128/JB.187.15.5496-5499.2005, 1196030, 16030245.
72. Zhang YX, Perry K, Vinci VA, Powell K, Stemmer WP, del Cardayre SB. Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature 2002, 415(6872):644-646. 10.1038/415644a, 11832946.
73. Patnaik R, Louie S, Gavrilovic V, Perry K, Stemmer WP, Ryan CM, del Cardayre S. Genome shuffling of Lactobacillus for improved acid tolerance. Nat Biotechnol 2002, 20(7):707-712. 10.1038/nbt0702-707, 12089556.
74. Dai M, Copley SD. Genome shuffling improves degradation of the anthropogenic pesticide pentachlorophenol by Sphingobium chlorophenolicum ATCC 39723. Appl Environ Microbiol 2004, 70(4):2391-2397. 10.1128/AEM.70.4.2391-2397.2004, 383174, 15066836.
75. Dai M, Ziesman S, Ratcliffe T, Gill RT, Copley SD. Visualization of protoplast fusion and quantitation of recombination in fused protoplasts of auxotrophic strains of Escherichia coli. Metab Eng 2005, 7(1):45-52. 10.1016/j.ymben.2004.09.002, 15974564.
76. Link AJ, Jeong KJ, Georgiou G. Beyond toothpicks: new methods for isolating mutant bacteria. Nat Rev Microbiol 2007, 5(9):680-688. 10.1038/nrmicro1715, 17676054.
77. Maxwell KL, et al. A simple in vivo assay for increased protein solubility. Protein Science 1999, 8(9):1908-1911. 10.1110/ps.8.9.1908, 2144404, 10493593.
78. Maxwell KL, Mittermaier AK, Forman-Kay JD, Davidson AR. A simple in vivo assay for increased protein solubility. Protein Science 1999, 8(9):1908-1911. 10.1110/ps.8.9.1908, 2144404, 10493593.
79. Liu JW, Boucher Y, Stokes HW, Ollis DL. Improving protein solubility: the use of the Escherichia coli dihydrofolate reductase gene as a fusion reporter. Protein Expr Purif 2006, 47(1):258-263. 10.1016/j.pep.2005.11.019, 16403649.
80. Japrung D, Chusacultanachai S, Yuvaniyama J, Wilairat P, Yuthavong Y. A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubility. Protein Eng Des Sel 2005, 18(10):457-464. 10.1093/protein/gzi044, 16120637.
81. Wigley WC, Stidham RD, Smith NM, Hunt JF, Thomas PJ. Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. Nat Biotechnol 2001, 19(2):131-136. 10.1038/84389, 11175726.
82. Foit L, Morgan GJ, Kern MJ, Steimer LR, von Hacht AA, Titchmarsh J, Warriner SL, Radford SE, Bardwell JC. Optimizing protein stability in vivo. Mol Cell 2009, 36(5):861-871. 10.1016/j.molcel.2009.11.022, 2818778, 20005848.
83. Cabantous S, Pedelacq JD, Mark BL, Naranjo C, Terwilliger TC, Waldo GS. Recent advances in GFP folding reporter and split-GFP solubility reporter technologies. Application to improving the folding and solubility of recalcitrant proteins from Mycobacterium tuberculosis. J Struct Funct Genomics 2005, 6(2-3):113-119. 10.1007/s10969-005-5247-5, 16211507.
84. Cabantous S, Terwilliger TC, Waldo GS. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 2005, 23(1):102-107. 10.1038/nbt1044, 15580262.
85. Cabantous S, Waldo GS. In vivo and in vitro protein solubility assays using split GFP. Nat Methods 2006, 3(10):845-854. 10.1038/nmeth932, 16990817.
86. Fisher AC, Kim W, DeLisa MP. Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway. Protein Sci 2006, 15(3):449-458. 10.1110/ps.051902606, 2249766, 16452624.
87. Lee PA, Tullman-Ercek D, Georgiou G. The bacterial twin-arginine translocation pathway. Annu Rev Microbiol 2006, 60:373-395. 10.1146/annurev.micro.60.080805.142212, 2654714, 16756481.
88. Waldo GS, Standish BM, Berendzen J, Terwilliger TC. Rapid protein-folding assay using green fluorescent protein. Nature Biotechnology 1999, 17(7):691-695. 10.1038/10904, 10404163.
89. Drew D, Sjostrand D, Nilsson J, Urbig T, Chin CN, de Gier JW, von Heijne G. Rapid topology mapping of Escherichia coli inner-membrane proteins by prediction and PhoA/GFP fusion analysis. Proc Natl Acad Sci USA 2002, 99(5):2690-2695. 10.1073/pnas.052018199, 122409, 11867724.
90. Kim KH, Yang JK, Waldo GS, Terwilliger TC, Suh SW. From no expression to high-level soluble expression in Escherichia coli by screening a library of the target proteins with randomized N-termini. Methods Mol Biol 2008, 426:187-195. 10.1007/978-1-60327-058-8_11, 18542864.
91. Coleman MA, Lao VH, Segelke BW, Beernink PT. High-throughput, fluorescence-based screening for soluble protein expression. J Proteome Res 2004, 3(5):1024-1032. 10.1021/pr049912g, 15473692.
92. Omoya K, Kato Z, Matsukuma E, Li A, Hashimoto K, Yamamoto Y, Ohnishi H, Kondo N. Systematic optimization of active protein expression using GFP as a folding reporter. Protein Expr Purif 2004, 36(2):327-332. 10.1016/j.pep.2004.04.023, 15249057.
93. Cabantous S, Rogers Y, Terwilliger TC, Waldo GS. New molecular reporters for rapid protein folding assays. PLoS One 2008, 3(6):e2387. 10.1371/journal.pone.0002387, 2408556, 18545698.
94. Chen G, Hayhurst A, Thomas JG, Harvey BR, Iverson BL, Georgiou G. Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS). Nat Biotechnol 2001, 19(6):537-542. 10.1038/89281, 11385457.
95. Klein-Marcuschamer D, Stephanopoulos G. Assessing the potential of mutational strategies to elicit new phenotypes in industrial strains. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(7):2319-2324. 10.1073/pnas.0712177105, 2268134, 18252819.